Related references
Note: Only part of the references are listed.Metabolomic study of lipids in serum for biomarker discovery in Alzheimer's disease using direct infusion mass spectrometry
R. Gonzalez-Dominguez et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2014)
Plasma Metabolite Profiles of Alzheimer's Disease and Mild Cognitive Impairment
Gang Wang et al.
JOURNAL OF PROTEOME RESEARCH (2014)
Combination of metabolomic and phospholipid-profiling approaches for the study of Alzheimer's disease
Raul Gonzalez-Dominguez et al.
JOURNAL OF PROTEOMICS (2014)
Method development and validation for rat serum fingerprinting with CE-MS: application to ventilator-induced-lung-injury study
Shama Naz et al.
ANALYTICAL AND BIOANALYTICAL CHEMISTRY (2013)
A new metabolomic workflow for early detection of Alzheimer's disease
Clara Ibanez et al.
JOURNAL OF CHROMATOGRAPHY A (2013)
Alzheimer's disease: amino acid levels and brain metabolic status
Maria Concetta Gueli et al.
NEUROLOGICAL SCIENCES (2013)
Effect of a nutraceutical treatment on diabetic rats with targeted and CE-MS non-targeted approaches
Joanna Godzien et al.
METABOLOMICS (2013)
Identification of Altered Metabolic Pathways in Plasma and CSF in Mild Cognitive Impairment and Alzheimer's Disease Using Metabolomics
Eugenia Trushina et al.
PLOS ONE (2013)
Alterations in metabolic pathways and networks in Alzheimer's disease
R. Kaddurah-Daouk et al.
TRANSLATIONAL PSYCHIATRY (2013)
Comparing metabolomic and pathologic biomarkers alone and in combination for discriminating Alzheimer's disease from normal cognitive aging
Alison A. Motsinger-Reif et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2013)
Toward a Predictive Model of Alzheimer's Disease Progression Using Capillary Electrophoresis-Mass Spectrometry Metabolomics
Clara Ibanez et al.
ANALYTICAL CHEMISTRY (2012)
Multiple Defects in Energy Metabolism in Alzheimers Disease
I. L. Ferreira et al.
CURRENT DRUG TARGETS (2012)
Identification of a new plasma biomarker of Alzheimer's disease using metabolomics technology
Yoshiaki Sato et al.
JOURNAL OF LIPID RESEARCH (2012)
Brain imaging in the study of Alzheimer's disease
Eric M. Reiman et al.
NEUROIMAGE (2012)
Metabolite Profiling of Alzheimer's Disease Cerebrospinal Fluid
Christian Czech et al.
PLOS ONE (2012)
Mining the Unknown: A Systems Approach to Metabolite Identification Combining Genetic and Metabolic Information
Jan Krumsiek et al.
PLOS GENETICS (2012)
Metabolomic changes in autopsy-confirmed Alzheimer's disease
Rima Kaddurah-Daouk et al.
ALZHEIMERS & DEMENTIA (2011)
Programmed Nebulizing Gas Pressure for Efficient and Stable Capillary Electrophoresis-Mass Spectrometry Analysis of Anionic Compounds in Positive Separation Mode
Javier Dominguez-Alvarez et al.
ANALYTICAL CHEMISTRY (2011)
Hippocampal Proton MR Spectroscopy in Early Alzheimer's Disease and Mild Cognitive Impairment
Catherine M. L. Foy et al.
BRAIN TOPOGRAPHY (2011)
Analysis of chiral amino acids in cerebrospinal fluid samples linked to different stages of Alzheimer disease
Shorena Samakashvili et al.
ELECTROPHORESIS (2011)
Capillary electrophoresis as a metabolomics tool for non-targeted fingerprinting of biological samples
C. Barbas et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2011)
Comprehensive Plasma Thiol Redox Status Determination for Metabolomics
Lisa A. D'Agostino et al.
JOURNAL OF PROTEOME RESEARCH (2011)
Serum 27-nor-5β-Cholestane-3,7,12,24,25 Pentol Glucuronide Discovered by Metabolomics as Potential Diagnostic Biomarker for Epithelium Ovarian Cancer
Jing Chen et al.
JOURNAL OF PROTEOME RESEARCH (2011)
Metabolomics in Early Alzheimer's Disease: Identification of Altered Plasma Sphingolipidome Using Shotgun Lipidomics
Xianlin Han et al.
PLOS ONE (2011)
Mitochondrial dysfunction and Alzheimer's disease
Aleksandra Maruszak et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2011)
Metabolome in progression to Alzheimer's disease
M. Oresic et al.
TRANSLATIONAL PSYCHIATRY (2011)
Quantitative and Wide-Ranging Profiling of Phospholipids in Human Plasma by Two-dimensional Liquid Chromatography/Mass Spectrometry
Yoshiaki Sato et al.
ANALYTICAL CHEMISTRY (2010)
Plasma metabolic profiling of Alzheimer's disease by liquid chromatography/mass spectrometry
Nai-jing Li et al.
CLINICAL BIOCHEMISTRY (2010)
One-Carbon Metabolism and Alzheimer's Disease: Focus on Epigenetics
Fabio Coppede
CURRENT GENOMICS (2010)
The clinical manifestation of MCAD deficiency: challenges towards adulthood in the screened population
Ulrich A. Schatz et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2010)
S-Adenosylmethionine Is Decreased in the Cerebrospinal Fluid of Patients with Alzheimer's Disease
Michael Linnebank et al.
NEURODEGENERATIVE DISEASES (2010)
Proteases and Proteolysis in Alzheimer Disease: A Multifactorial View on the Disease Process
Bart De Strooper
PHYSIOLOGICAL REVIEWS (2010)
Quantitative Profiling of Polar Cationic Metabolites in Human Cerebrospinal Fluid by Reversed-Phase Nanoliquid Chromatography/Mass Spectrometry
Khin Than Myint et al.
ANALYTICAL CHEMISTRY (2009)
Hyperhomocysteinemia and Alzheimer's disease: A systematic review
Floris Van Dam et al.
ARCHIVES OF GERONTOLOGY AND GERIATRICS (2009)
A Possible New Diagnostic Biomarker in Early Diagnosis of Alzheimer's Disease
Felix Kork et al.
CURRENT ALZHEIMER RESEARCH (2009)
A proposed metabolic strategy for monitoring disease progression in Alzheimer's disease
Nicola Greenberg et al.
ELECTROPHORESIS (2009)
Measurement of homocysteine and related metabolites in human plasma and urine by liquid chromatography electrospray tandem mass spectrometry
Mahroukh Rafii et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2009)
Angiotensins in Alzheimer's disease - friend or foe?
Patrick G. Kehoe et al.
TRENDS IN NEUROSCIENCES (2009)
Longitudinal Metabolic and Cognitive Changes in Mild Cognitive Impairment Patients
Brenda L. Bartnik Olson et al.
ALZHEIMER DISEASE & ASSOCIATED DISORDERS (2008)
A multi-metabolite analysis of serum by 1H NMR spectroscopy:: Early systemic signs of Alzheimer's disease
Taru Tukiainen et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2008)
Asymmetrical dimethylarginine is increased in plasma and decreased in cerebrospinal fluid of patients with Alzheimer's disease
Soenke Arlt et al.
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS (2008)
Creatine and Its Potential Therapeutic Value for Targeting Cellular Energy Impairment in Neurodegenerative Diseases
Peter J. Adhihetty et al.
NEUROMOLECULAR MEDICINE (2008)
Quantification of 1H NMR spectra of human cerebrospinal fluid:: a protocol based on constrained total-line-shape analysis
Niko M. Jukarainen et al.
METABOLOMICS (2008)
Metabolome analysis by capillary electrophoresis-mass spectrometry
Maria Rowena N. Monton et al.
JOURNAL OF CHROMATOGRAPHY A (2007)
Research criteria for the diagnosis of Alzheimers disease: revising the NINCDS-ADRDA criteria
Bruno Dubois et al.
LANCET NEUROLOGY (2007)
Free amino acid and dipeptide changes in the body fluids from Alzheimer's disease subjects
A. N. Fonteh et al.
AMINO ACIDS (2007)
Biomarkers for Alzheimer's disease
Malcolm Ward
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2007)
Urinary polyamines and N-acetylated polyamines in four patients with Alzheimer's disease as their N-ethoxycarbonyl-N-pentafluoropropionyl derivatives by gas chromatography-mass spectrometry in selected ion monitoring mode
Man-Jeong Paik et al.
ANALYTICA CHIMICA ACTA (2006)
Centering, scaling, and transformations: improving the biological information content of metabolomics data
Robert A. van den Berg et al.
BMC GENOMICS (2006)
Decreased plasma antioxidants in patients with Alzheimer's disease
TS Kim et al.
INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY (2006)
A pragmatic and readily implemented quality control strategy for HPLC-MS and GC-MS-based metabonomic analysis
Timothy Sangster et al.
ANALYST (2006)
3-Hydroxyacyl-CoA dehydrogenase and short chain 3-hydroxyacyl-CoA dehydrogenase in human health and disease
SY Yang et al.
FEBS JOURNAL (2005)
Health co-morbidities in ageing persons with Down syndrome and Alzheimer's dementia
M McCarron et al.
JOURNAL OF INTELLECTUAL DISABILITY RESEARCH (2005)
Mitochondrial abnormalities in Alzheimer brain: Mechanistic implications
P Bubber et al.
ANNALS OF NEUROLOGY (2005)
Metabonomics and its role in drug development and disease diagnosis
JC Lindon et al.
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2004)
Mild cognitive impairment as a diagnostic entity
RC Petersen
JOURNAL OF INTERNAL MEDICINE (2004)
Glycerophosphocholine is elevated in cerebrospinal fluid of Alzheimer patients
A Walter et al.
NEUROBIOLOGY OF AGING (2004)
Increased concentrations of homocysteine and asymmetric dimethylarginine and decreased concentrations of nitric oxide in the plasma of patients with Alzheimer's disease
ML Selley
NEUROBIOLOGY OF AGING (2003)
Mild cognitive impairment: prevalence, prognosis, aetiology, and treatment
C DeCarli
LANCET NEUROLOGY (2003)
Plasma homocysteine as a risk factor for dementia and Alzheimer's disease.
S Seshadri et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Current concepts in mild cognitive impairment
RC Petersen et al.
ARCHIVES OF NEUROLOGY (2001)
Vascular risk factors for Alzheimer's disease: An epidemiologic perspective
MMB Breteler
NEUROBIOLOGY OF AGING (2000)
Inflammation and Alzheimer's disease
H Akiyama et al.
NEUROBIOLOGY OF AGING (2000)
Share Paper
